Form 4 for GILD Gilead Sciences
Accepted 2023-12-11 00:00:00 ET · period of report 2023-12-10 · accession 0001127602-23-029247 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-11 | 2023-12-10 | GILD | Parsey Merdad | Chief Medical Off | M - OptEx | — | +2,779 | 72.9K | +4% | — |
| D | 2023-12-11 | 2023-12-10 | GILD | Parsey Merdad | Chief Medical Off | F - Tax | $79.02 | -1,269 | 71.6K | -2% | -$100.3K |
| D | 2023-12-11 | 2023-12-10 | GILD | Parsey Merdad | Chief Medical Off | M - OptEx | — | -2,779 | 41.0K | -6% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-10 | M | A | 2,779 | — | 72,909 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 2 | Common | Common Stock | 2023-12-10 | F | D | 1,269 | $79.02 | 71,640 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2023-12-10 | M | D | 2,779 | — | 40,975 | D | — · — to — | 2,779 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested. |